ProShare Advisors’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
SCM
FLAM
ProShare Advisors's ORGO Position: Q1 2026 in Review
ProShare Advisors sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 12,483 shares — an estimated $64.7K sold.
ProShare Advisors first reported a position in ORGO in Q2 2021 and held it in 12 quarters. The position peaked at $187K in Q2 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.
- ProShare Advisors reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
- ProShare Advisors sold 12,483 Organogenesis Holdings shares in Q1 2026, an estimated $64.7K.
- ProShare Advisors first reported a position in Organogenesis Holdings in Q2 2021 and held it in 12 quarters.
- ProShare Advisors's Organogenesis Holdings position peaked at $187K in Q2 2021.
- 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.
Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.